Joanna Romejko

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We analysed the outcome of 200 patients, aged 38 (13-72) years, with aggressive non-Hodgkin's lymphoma (NHL) treated with high-dose chemotherapy followed by autologous haematopoietic stem cell(More)
  • 1